Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$111.29 USD
+0.65 (0.59%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $111.30 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZBH 111.29 +0.65(0.59%)
Will ZBH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ZBH
Here's How Zimmer Biomet (ZBH) is Poised Ahead of Q2 Earnings
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Other News for ZBH
Dodge & Cox Stock Fund Q2 2024 Shareholder Letter
Noteworthy Wednesday Option Activity: ZBH, V, NOW
Dodge & Cox Stock Fund's 2nd-Quarter Commentary: A Recap
Interesting ZBH Put And Call Options For March 2025
Osstem Implant in advanced talks to buy ZimVie, Bloomberg reports